Athira Pharma Ownership | Who Owns Athira Pharma?


OverviewForecastFinancialsChart

Athira Pharma Ownership Summary


Athira Pharma is owned by 46.46% institutional investors, 2.93% insiders, and 50.61% retail investors. Perceptive advisors is the largest institutional shareholder, holding 14.03% of ATHA shares. Simplify Propel Opportunities ETF is the top mutual fund, with 3.82% of its assets in Athira Pharma shares.

ATHA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAthira Pharma46.46%2.93%50.61%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Perceptive advisors5.40M14.03%$3.17M
Bml capital management2.78M7.21%$1.63M
Vanguard group1.56M4.04%$913.75K
Propel bio management1.49M3.88%$875.82K
Simplify asset management1.49M3.88%$875.82K
Blackrock676.24K1.76%$1.79M
Tang capital management600.00K1.56%$352.02K
Jacobs levy equity management506.81K1.32%$1.34M
Blackrock funding, inc. /de458.76K1.19%$269.16K
Acadian asset management434.49K1.13%$254.00K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bml capital management2.78M1.01%$1.63M
Propel bio management1.49M0.87%$875.82K
Perceptive advisors5.40M0.09%$3.17M
Simplify asset management1.49M0.04%$875.82K
Tang capital management600.00K0.02%$352.02K
Bristlecone advisors337.51K0.02%$198.01K
Gsa capital partners llp296.56K0.01%$174.00K
Integrity financial corp /wa32.79K0.01%$19.24K
Laird norton trust company127.31K0.01%$74.69K
Invst27.00K0.01%$67.77K

Top Buyers

HolderShares% AssetsChange
Bml capital management2.78M1.01%2.78M
Qube research350.01K0.00%286.97K
Royal bank of canada183.02K-174.68K
Ubs group86.98K-75.15K
Hrt financial lp42.75K0.00%42.75K

Top Sellers

HolderShares% AssetsChange
Baker bros. advisors lp---3.15M
Wasatch advisors lp---1.30M
Dimensional fund advisors lp---321.45K
Two sigma investments, lp---258.47K
Renaissance207.30K0.00%-245.49K

New Positions

HolderShares% AssetsChangeValue
Hrt financial lp42.75K0.00%42.75K$25.00K
Vanguard personalized indexing management38.98K0.00%38.98K$22.87K
Invst27.00K0.01%27.00K$67.77K
Shay capital11.80K0.00%11.80K$6.92K
Bnp paribas arbitrage, snc1.36K-1.36K$798.00

Sold Out

HolderChange
Citigroup-75.00
Householder group estate & retirement specialist-150.00
Mather group, llc.-175.00
Wells fargo & company/mn-238.00
Macquarie group-520.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202454-8.47%17,895,38910.96%462.65%12-52.00%2150.00%
Sep 30, 202459-14.49%16,127,283-27.33%411.25%2566.67%14-39.13%
Jun 30, 202469-12.66%22,193,5502.25%571.79%15-58.33%2327.78%
Mar 31, 20247917.91%21,705,121-0.90%561.72%3663.64%18-10.00%
Dec 31, 202367-8.22%21,901,5532.19%571.81%2222.22%20-33.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Simplify Propel Opportunities ETF1.49M3.82%-
Vanguard US Total Market Shares ETF1.12M2.87%-
Vanguard Total Stock Mkt Idx Inv1.07M2.75%-
Wasatch Micro Cap646.90K1.68%646.90K
Wasatch Ultra Growth544.27K1.42%544.27K
Vanguard Institutional Extnd Mkt Idx Tr452.02K1.16%-
Fidelity Extended Market Index166.24K0.43%-1.06K
DFA US Small Cap I88.44K0.23%3.34K
iShares Micro-Cap ETF74.02K0.19%-
BlackRock Extended Equity Market K67.36K0.18%-29.00

Recent Insider Transactions


DateNameRoleActivityValue
Jan 02, 2025San Martin Javier CHIEF MEDICAL OFFICERSell$6.08K
Jan 02, 2025Litton Mark James President and CEOSell$14.11K
Jan 02, 2025CHURCH KEVIN CHIEF SCIENTIFIC OFFICERSell$4.78K
Jan 02, 2025Renninger Robert VP of FinanceSell$1.62K
Jan 02, 2025Worthington Mark General Counsel and CCOSell$4.78K

Insider Transactions Trends


DateBuySell
2025 Q1-5
2024 Q4--
2024 Q3-5
2024 Q22-
2024 Q1-5

ATHA Ownership FAQ


Who Owns Athira Pharma?

Athira Pharma shareholders are primarily institutional investors at 46.46%, followed by 2.93% insiders and 50.61% retail investors. The average institutional ownership in Athira Pharma's industry, Biotech Stocks , is 68.48%, which Athira Pharma falls below.

Who owns the most shares of Athira Pharma?

Athira Pharma’s largest shareholders are Perceptive advisors (5.4M shares, 14.03%), Bml capital management (2.78M shares, 7.21%), and Vanguard group (1.56M shares, 4.04%). Together, they hold 25.28% of Athira Pharma’s total shares outstanding.

Does Blackrock own Athira Pharma?

Yes, BlackRock owns 1.76% of Athira Pharma, totaling 676.24K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.79M$. In the last quarter, BlackRock increased its holdings by 8.97K shares, a 1.34% change.

Who is Athira Pharma’s biggest shareholder by percentage of total assets invested?

Bml capital management is Athira Pharma’s biggest shareholder by percentage of total assets invested, with 1.01% of its assets in 2.78M Athira Pharma shares, valued at 1.63M$.

Who is the top mutual fund holder of Athira Pharma shares?

Simplify Propel Opportunities ETF is the top mutual fund holder of Athira Pharma shares, with 3.82% of its total shares outstanding invested in 1.49M Athira Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools